Refine
Year of publication
Document Type
- Article (30)
- Postprint (3)
- Doctoral Thesis (1)
Language
- English (34)
Is part of the Bibliography
- yes (34)
Keywords
Institute
- Institut für Physik und Astronomie (12)
- Institut für Biochemie und Biologie (7)
- Institut für Chemie (4)
- Hasso-Plattner-Institut für Digital Engineering GmbH (3)
- Institut für Mathematik (2)
- Institut für Umweltwissenschaften und Geographie (2)
- Department Psychologie (1)
- Hasso-Plattner-Institut für Digital Engineering gGmbH (1)
- Institut für Ernährungswissenschaft (1)
- Institut für Geowissenschaften (1)
- Mathematisch-Naturwissenschaftliche Fakultät (1)
Temporally changing drivers for late-Holocene vegetation changes on the northern Tibetan Plateau
(2012)
Fossil pollen records have been widely used as indicators of past changes in vegetation and variations in climate. The driving mechanisms behind these vegetation changes have, however, remained unclear. In order to evaluate vegetation changes that have occurred in the northern part of the Tibetan Plateau and the possible drivers behind these changes, we have applied a moving-window Redundancy Analysis (RDA) to high resolution (10-15 years) pollen and sedimentary data from Lake Kusai covering the last 3770 years. Our analyses reveal frequent fluctuations in the relative abundances of alpine steppe and alpine desert components. The sedimentary proxies (including total organic carbon content, total inorganic carbon content, and "end-member" indices from grain-size analyses) that explain statistically some of the changes in the pollen assemblage vary significantly with time, most probably reflecting multiple underlying driving processes. Climate appears to have had an important influence on vegetation changes when conditions were relatively wet and stable. However, a gradual decrease in vegetation cover was identified after 1500 cal a BP, after which the vegetation appears to have been affected more by extreme events such as dust-storms or fluvial erosion than by general climatic trends. Furthermore, pollen spectra over the last 600 years are shown by Procrustes analysis to be statistically different from those recovered from older samples, which we attribute to increased human impact that resulted in unprecedented changes to the vegetation composition. Overall, changes in vegetation and climate on the northern part of the Tibetan Plateau appear to have roughly followed the evolution of the Asian Summer Monsoon. After taking into account the highly significant millennial (1512 years) periodicity revealed by time-series analysis, the regional vegetation and climate changes also show variations that appear to match variations in the mid-latitude westerlies.
The retinitis pigmentosa 2 polypeptide (RP2) functions as a GTPase-activating protein (GAP) for ARL3 (Arf-like protein 3), a small GTPase. ARL3 is an effector of phosphodiesterase 6 Delta (PDE6D), a prenyl-binding protein and chaperone of prenylated protein in photoreceptors. Mutations in the human RP2 gene cause X-linked retinitis pigmentosa (XLRP) and cone-rod dystrophy (XL-CORD). To study mechanisms causing XLRP, we generated an RP2 knockout mouse. The RP2h(-/-) mice exhibited a slowly progressing rod-cone dystrophy simulating the human disease. RP2h(-/-) scotopic a-wave and photopic b-wave amplitudes declined at 1 mo of age and continued to decline over the next 6 mo. Prenylated PDE6 subunits and G-protein coupled receptor kinase 1 (GRK1) were unable to traffic effectively to the RP2h(-/-) outer segments. Mechanistically, absence of RP2 GAP activity increases ARL3-GTP levels, forcing PDE6D to assume a predominantly "closed" conformation that impedes binding of lipids. Lack of interaction disrupts trafficking of PDE6 and GRK1 to their destination, the photoreceptor outer segments. We propose that hyperactivity of ARL3-GTP in RP2 knockout mice and human patients with RP2 null alleles leads to XLRP resembling recessive rod-cone dystrophy.
Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to identify genetic loci for rapid eGFRcrea decline. Two definitions of eGFRcrea decline were used: 3 mL/min/1.73m(2)/year or more ("Rapid3"; encompassing 34,874 cases, 107,090 controls) and eGFRcrea decline 25% or more and eGFRcrea under 60 mL/min/1.73m(2) at follow-up among those with eGFRcrea 60 mL/min/1.73m(2) or more at baseline ("CKDi25"; encompassing 19,901 cases, 175,244 controls). Seven independent variants were identified across six loci for Rapid3 and/or CKDi25: consisting of five variants at four loci with genome-wide significance (near UMOD-PDILT (2), PRKAG2, WDR72, OR2S2) and two variants among 265 known eGFRcrea variants (near GATM, LARP4B). All these loci were novel for Rapid3 and/or CKDi25 and our bioinformatic follow-up prioritized variants and genes underneath these loci. The OR2S2 locus is novel for any eGFRcrea trait including interesting candidates. For the five genome-wide significant lead variants, we found supporting effects for annual change in blood urea nitrogen or cystatin-based eGFR, but not for GATM or (LARP4B). Individuals at high compared to those at low genetic risk (8-14 vs. 0-5 adverse alleles) had a 1.20-fold increased risk of acute kidney injury (95% confidence interval 1.08-1.33). Thus, our identified loci for rapid kidney function decline may help prioritize therapeutic targets and identify mechanisms and individuals at risk for sustained deterioration of kidney function.
Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to identify genetic loci for rapid eGFRcrea decline. Two definitions of eGFRcrea decline were used: 3 mL/min/1.73m(2)/year or more ("Rapid3"; encompassing 34,874 cases, 107,090 controls) and eGFRcrea decline 25% or more and eGFRcrea under 60 mL/min/1.73m(2) at follow-up among those with eGFRcrea 60 mL/min/1.73m(2) or more at baseline ("CKDi25"; encompassing 19,901 cases, 175,244 controls). Seven independent variants were identified across six loci for Rapid3 and/or CKDi25: consisting of five variants at four loci with genome-wide significance (near UMOD-PDILT (2), PRKAG2, WDR72, OR2S2) and two variants among 265 known eGFRcrea variants (near GATM, LARP4B). All these loci were novel for Rapid3 and/or CKDi25 and our bioinformatic follow-up prioritized variants and genes underneath these loci. The OR2S2 locus is novel for any eGFRcrea trait including interesting candidates. For the five genome-wide significant lead variants, we found supporting effects for annual change in blood urea nitrogen or cystatin-based eGFR, but not for GATM or (LARP4B). Individuals at high compared to those at low genetic risk (8-14 vs. 0-5 adverse alleles) had a 1.20-fold increased risk of acute kidney injury (95% confidence interval 1.08-1.33). Thus, our identified loci for rapid kidney function decline may help prioritize therapeutic targets and identify mechanisms and individuals at risk for sustained deterioration of kidney function.